GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)
| 23.79 Delayed Data As of 1:25pm ET |  +0.34 / +1.45%Today’s Change | 18.74 Today|||52-Week Range 24.20 | +0.70% Year-to-Date |
Latest GLAXF News | Press Releases
| 5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals Jan 16 / MotleyFool.com - Paid Partner Content | Is Pfizer's Stock a Buy? Jan 14 / MotleyFool.com - Paid Partner Content |
| Here's Why Clovis Oncology Rose as Much as 25.6% Today Jan 15 / MotleyFool.com - Paid Partner Content | Here's Why SpringWorks Therapeutics Climbed 69% in December Jan 12 / MotleyFool.com - Paid Partner Content |
| FDA Gives Clovis Oncology's Rubraca a Priority Review Jan 15 / MotleyFool.com - Paid Partner Content | 3 Dividend Stocks Yielding More Than 4% That Are Safe Buys in 2020 Jan 11 / MotleyFool.com - Paid Partner Content |
| Will Theravance Biopharma Finally Break Out in 2020? Jan 14 / MotleyFool.com - Paid Partner Content | Axsome Therapeutics: Buy at the High? Jan 07 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 23.45 |
| Today’s open | 23.79 |
| Day’s range | 23.79 - 24.20 |
| Volume | 984 |
| Average volume (3 months) | 5,828 |
| Market cap | $117.5B |
Data as of 1:25pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +143.10% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +5.72% |
| P/E ratio | 16.5 |
| Price/Sales | 2.30 |
| Price/Book | 20.87 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $4.8B |
| Net profit margin | 11.75% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Brentford, Greater London |
Forecasts
